Since blocking IL-1 with IL-1ra has failed as a sepsis therapy (Fisher et al., 1994; Opal et al., 1997), it is difficult to understand how blocking IL-1 would benefit COVID-19 patients but not sepsis patients. This evidence concerns the gene IL1B and COVID-19.